ランダム化試験における安全性報告の完全性: 7つの医療領域の評価
1Clinical Trials and Evidence-Based Medicine Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
JAMA
|March 10, 2001
まとめ
ランダム化試験における安全性報告は,しばしば不十分である. この研究では,有害作用と毒性による治療中止の報告方法の有意な変動が認められ,基準の見直しが必要となった.
科学分野:
- クリニック・リサーチ 臨床研究
- 医薬品監視 医薬品監視
- 医療統計 医療統計について
背景:
- ランダム化試験は,新薬の安全性を評価する上で極めて重要です.
- しかし,これらの試験における薬物安全性報告に関する包括的なデータは依然として限られている.
研究 の 目的:
- ランダム化薬物試験における安全性報告の完全性と質を評価する.
- 安全報告の範囲に影響を与える要因を特定する.
主な方法:
- 7つの医療分野における192件のランダム化薬物試験の調査です.
- 分析は,副作用,毒性,治療中止の報告に焦点を当てました.
- 安全データとその予測要因のためのスペースの割り当てを検証した.
主要な成果:
- 副作用の重度と毒性の適切な定義は,試験のそれぞれ39%と29%でしか見つかりませんでした.
- 臨床試験の半数未満 (46%) が,毒性による治療中止の具体的な理由を報告した.
- 安全性に関する報告は,さまざまな医学的なトピックと研究デザインによって著しく異なっていた.
結論:
- ランダム化試験における安全性報告の質と量は,一般的に不十分である.
- 医療分野や試験の特徴にわたる安全性報告には大きな格差がある.
- 現在の安全報告の基準は,適切なデータプレゼンテーションを確保するために改訂する必要があります.
関連する概念動画
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Types of Reports II: Incident or Occurrence Report
An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...
